Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22004245 | 0.91 | HSD11B1 (0.33) | ALDH1A1NPSR1 | |
| SCHEMBL13464729 | 0.82 | LMNA (0.33) | LMNAEPHX2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL21754744 | 0.81 | LMNA (0.36) | LMNAEPHX2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL19387776 | 0.79 | ALDH1A1 (0.34) | EPHX2ALDH1A1MAPT | |
| SCHEMBL15186548 | 0.78 | EPHX2 (0.31) | EPHX2 | |
| SCHEMBL22759048 | 0.78 | EPHX2 (0.31) | EPHX2 | |
| SCHEMBL17066105 | 0.77 | HSD11B1 (0.36) | LMNAALDH1A1TSHRNPSR1 | |
| SCHEMBL15183217 | 0.77 | LMNA (0.32) | LMNAEPHX2ALDH1A1 | |
| SCHEMBL15655907 | 0.76 | HSD11B1 (0.38) | LMNAALDH1A1TSHR | |
| SCHEMBL15183242 | 0.76 | LMNA (0.32) | LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11385542-B2 | Salt, quencher, resist composition and method for producing resist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-07-12 | — | — | US | disclosed |
| US-20200159116-A1 | SALT, QUENCHER, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200159116-A1 | SALT, QUENCHER, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SLC11A2, MSR1, NHERF1 | LMNA 3801/4885EPHX2 2797/4885CYP3A4 879/4885 |
| US-11385542-B2 | Salt, quencher, resist composition and method for producing resist pattern | SLC11A2, MSR1, NHERF1 | LMNA 3801/4885EPHX2 2797/4885CYP3A4 879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.